Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai Population
NCT01172613 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2010-07-30
Summary
The purpose of this study is to determine the appropriate concentration of diagnostic reagent of house dust mite (Dp) to be used in diagnostic allergy skin prick test among Thai population with allergic rhinitis.
Conditions
- Rhinitis, Allergic, Perennial
- Rhinitis, Allergic, Seasonal
- Skin Prick Test
Sponsors & Collaborators
-
Siriraj Hospital
lead OTHER
Principal Investigators
-
Professor Pakit Vichyanond, MD · Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University
Eligibility
- Min Age
- 15 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2010-12-31
Countries
- Thailand
Study Locations
More Related Trials
-
The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic Rhinitis
NCT01068808 ·Status: COMPLETED
-
Dust Mite Allergen Reduction Study
NCT00339690 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
NCT07060885 ·Status: RECRUITING ·Phase: PHASE3
-
Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract
NCT01821716 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Olopatadine Nasal Spray
NCT00578331 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between Local and Imported Skin Prick Testing Result of Rat and Mouse Allergen Extracts
NCT03645161 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients
NCT04984941 ·Status: COMPLETED
-
House Dust Mite Allergy Trial In Children
NCT04145219 ·Status: COMPLETED ·Phase: PHASE3
-
Immunoblot, Chemiluminescence and ImmunoCap Allergen Specific IgE Evaluation of in Allergic Rhinitis Patients
NCT06137495 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
NCT00263640 ·Status: COMPLETED ·Phase: PHASE3
-
Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR
NCT05570383 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis
NCT02301884 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of SLITone in House Dust Mite Allergic Patients
NCT00633919 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
NCT06920771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
House Dust Mite Injection Immunotherapy in Elderly Patients.
NCT03209245 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children
NCT01199133 ·Status: TERMINATED ·Phase: PHASE3
-
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
NCT01678807 ·Status: COMPLETED ·Phase: PHASE1
-
Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients
NCT02269566 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model
NCT01527188 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber
NCT04176185 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
NCT01013116 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis
NCT00674700 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR
NCT02443805 ·Status: COMPLETED ·Phase: PHASE3
-
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
NCT04915352 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites
NCT02881879 ·Status: COMPLETED ·Phase: PHASE1